Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8052)
All Articles published online
|
Publishing Process of This Article
|
Aug 7, 2014 (publication date) through Dec 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Spampatti M, Vlotides G, Spöttl G, Maurer J, Göke B, Auernhammer CJ. Aspirin inhibits cell viability and mTOR downstream signaling in gastroenteropancreatic and bronchopulmonary neuroendocrine tumor cells. World J Gastroenterol 2014; 20(29): 10038-10049 [PMID: 25110431 DOI: 10.3748/wjg.v20.i29.10038] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i29/10038.htm |
| Number | Citing Articles |
| 1 |
Federica Cavalcoli, Sara Pusceddu, Alessandra Zilli, Gianluca Tamagno, Daniela Femia, Natalie Prinzi, John Travers, Dario Consonni, Clorinda Ciafardini, Dario Conte, Sara Massironi. Effects of low-dose aspirin on clinical outcome and disease progression in patients with gastroenteropancreatic neuroendocrine neoplasm. Scandinavian Journal of Gastroenterology 2019; 54(9): 1111 doi: 10.1080/00365521.2019.1656773
|
| 2 |
Poulami Khan, Apoorva Bhattacharya, Debomita Sengupta, Shruti Banerjee, Arghya Adhikary, Tanya Das. Aspirin enhances cisplatin sensitivity of resistant non-small cell lung carcinoma stem-like cells by targeting mTOR-Akt axis to repress migration. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53134-0
|
| 3 |
Xi-Feng Jin, Gerald Spöttl, Julian Maurer, Svenja Nölting, Christoph Josef Auernhammer. Inhibition of Wnt/β-Catenin Signaling in Neuroendocrine Tumors In Vitro: Antitumoral Effects. Cancers 2020; 12(2): 345 doi: 10.3390/cancers12020345
|
| 4 |
E T Aristizabal Prada, C J Auernhammer. Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets. Endocrine Connections 2018; 7(1): R1 doi: 10.1530/EC-17-0286
|
| 5 |
Clemens Reuther, Vera Heinzle, Matilde Spampatti, George Vlotides, Enrico de Toni, Gerald Spöttl, Julian Maurer, Svenja Nölting, Burkhard Göke, Christoph J. Auernhammer. Cabozantinib and Tivantinib, but Not INC280, Induce Antiproliferative and Antimigratory Effects in Human Neuroendocrine Tumor Cells in vitro: Evidence for ‘Off-Target' Effects Not Mediated by c-Met Inhibition. Neuroendocrinology 2016; 103(3-4): 383 doi: 10.1159/000439431
|
| 6 |
Svenja Nölting, Julian Maurer, Gerald Spöttl, Elke Tatjana Aristizabal Prada, Clemens Reuther, Karen Young, Márta Korbonits, Burkhard Göke, Ashley Grossman, Christoph J. Auernhammer, Olorunseun Ogunwobi. Additive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling Pathways. PLOS ONE 2015; 10(12): e0143830 doi: 10.1371/journal.pone.0143830
|
| 7 |
Gerassimos Lascaratos, Kai-Yin Chau, Haogang Zhu, Despoina Gkotsi, Deborah Kamal, Ivan Gout, Philip J. Luthert, Anthony H.V. Schapira, David F. Garway-Heath. Systemic PTEN-Akt1-mTOR pathway activity in patients with normal tension glaucoma and ocular hypertension: A case series. Mitochondrion 2017; 36: 96 doi: 10.1016/j.mito.2017.05.003
|
| 8 |
Elke Tatjana Aristizabal Prada, Michael Orth, Svenja Nölting, Gerald Spöttl, Julian Maurer, Christoph Auernhammer, Olorunseun Ogunwobi. The MTH1 inhibitor TH588 demonstrates anti-tumoral effects alone and in combination with everolimus, 5-FU and gamma-irradiation in neuroendocrine tumor cells. PLOS ONE 2017; 12(5): e0178375 doi: 10.1371/journal.pone.0178375
|
| 9 |
Elke Tatjana Aristizabal Prada, Vera Heinzle, Thomas Knösel, Svenja Nölting, Gerald Spöttl, Julian Maurer, Christine Spitzweg, Martin Angele, Nina Schmidt, Felix Beuschlein, Günter K Stalla, Rainer Blaser, Klaus A Kuhn, Christoph J Auernhammer. Tropomyosin receptor kinase: a novel target in screened neuroendocrine tumors. Endocrine-Related Cancer 2018; 25(5): 547 doi: 10.1530/ERC-17-0201
|